Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALLO

Allogene Therapeutics Inc

Jun 18 • 04:00PM ET

2.00

+0.04 2.04 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SANA KRYS BMRN RYTM KYMR INCY NUVL VKTX AXSM NBIX

| Held by: VTI XBI IWM VXF IBB FESM IWN SCHA DFAS VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	24.58%	Shs Outstand	345.15M	Perf Week	6.38%
Market Cap	690.31M	Forward P/E	-	EPS next Y	-0.75	Insider Trans	-0.34%	Shs Float	260.30M	Perf Month	5.82%
Enterprise Value	504.47M	PEG	-	EPS next Q	-0.17	Inst Own	39.01%	Short Float	17.09%	Perf Quarter	-9.91%
Income	-173.76M	P/S	-	EPS this Y	19.26%	Inst Trans	7.12%	Short Ratio	4.40	Perf Half Y	29.87%
Sales	0.00M	P/B	1.76	EPS next Y	-6.71%	ROA	-38.45%	Short Interest	44.48M	Perf YTD	45.99%
Book/sh	1.14	P/C	2.59	EPS next 5Y	7.44%	ROE	-52.32%	52W High	4.46 -55.16%	Perf Year	55.04%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-49.43%	52W Low	0.98 103.21%	Perf 3Y	-58.76%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.06% 6.41%	Perf 5Y	-91.83%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	37.45%	Oper. Margin	-	ATR (14)	0.14	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	48.82	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	36.09%	SMA20	0.25%	Beta	0.47	Target Price	8.48
Payout	-	Debt/Eq	0.29	Sales Q/Q	-	SMA50	-7.83%	Rel Volume	2.33	Prev Close	1.96
Employees	152	LT Debt/Eq	0.26	Earnings	May 13 AMC	SMA200	13.78%	Avg Volume	10.11M	Price	2.00
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.31% -100.00%	Trades		Volume	23,540,380	Change	2.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)